HuGE Literature Finder
Records 1-25
|
Clinico-neuropathological features of isocitrate dehydrogenase 2 gene mutations in lower-grade gliomas.
Chinese medical journal 2019 Dec . Wang Lei-Ming, Li Zhuo, Piao Yue-Shan, Cai Yan-Ning, Zhang Li-Yan, Ge Hai-Jing, Xu Wei-Wei, Lu De-Ho |
|
The contribution of the rs55705857 G allele to familial cancer risk as estimated in the Utah population database.
BMC cancer 2019 Mar 19 (1): 190. Hummel Sarah, Kohlmann Wendy, Kollmeyer Thomas M, Jenkins Robert, Sonnen Joshua, Palmer Cheryl A, Colman Howard, Abbott Diana, Cannon-Albright Lisa, Cohen Adam |
|
The Correlation Between 1p/19q Codeletion, IDH1 Mutation, p53 Overexpression and Their Prognostic Roles in 41 Turkish Anaplastic Oligodendroglioma Patients.
Turkish neurosurgery 2016 Aug . Hacisalihoglu Payam, Kucukodaci Zafer, Gundogdu Gokcen, Bilgic Bil |
|
Isocitrate Dehydrogenase (IDH)1/2 Mutations as Prognostic Markers in Patients With Glioblastomas.
Medicine 2016 Mar 95 (9): e2583. Chen Jun-Rui, Yao Yu, Xu Hong-Zhi, Qin Zhi-Yo |
|
Prognostic significance of histomolecular subgroups of adult anaplastic (WHO Grade III) gliomas: applying the 'integrated' diagnosis approach.
Journal of clinical pathology 2016 Jan . Rajmohan K S, Sugur Harsha S, Shwetha S D, Ramesh Arvind, Thennarasu Kandavel, Pandey Paritosh, Arivazhagan Arimappamagan, Santosh Va |
|
ATRX immunostaining predicts IDH and H3F3A status in gliomas.
Acta neuropathologica communications 2016 4 (1): 60. Ebrahimi Azadeh, Skardelly Marco, Bonzheim Irina, Ott Ines, Mühleisen Helmut, Eckert Franziska, Tabatabai Ghazaleh, Schittenhelm Je |
|
Prevalence of IDH1/2 Mutations in Different Subtypes of Glioma in the North-East Population of Morocco.
Asian Pacific journal of cancer prevention : APJCP 2016 17 (5): 2649-53. Senhaji Nadia, Louati Sara, Chbani Laila, Bardai Sanae El, Mikou Karima, Maaroufi Mustafa, Benzagmout Mohammed, Faiz Mohammed Chaoui El, Marie Yannick, Mokhtari Karima, Idbaih Ahmed, Amarti Afaf, Bennis San |
|
Genetic and epigenetic characterization of low-grade gliomas reveals frequent methylation of the MLH3 gene.
Genes, chromosomes & cancer 2015 Nov 54 (11): 655-67. Lhotska Halka, Zemanova Zuzana, Cechova Hana, Ransdorfova Sarka, Lizcova Libuse, Kramar Filip, Krejcik Zdenek, Svobodova Karla, Bystricka Dagmar, Hrabal Petr, Dohnalova Alena, Michalova Ky |
|
Molecular classification of anaplastic oligodendroglioma using next-generation sequencing: a report of the prospective randomized EORTC Brain Tumor Group 26951 phase III trial.
Neuro-oncology 2015 Sep . Dubbink Hendrikus J, Atmodimedjo Peggy N, Kros Johan M, French Pim J, Sanson Marc, Idbaih Ahmed, Wesseling Pieter, Enting Roelien, Spliet Wim, Tijssen Cees, Dinjens Winand N M, Gorlia Thierry, van den Bent Martin |
|
Immunohistochemical profiles of IDH1, MGMT and P53: practical significance for prognostication of patients with diffuse gliomas.
Neuropathology : official journal of the Japanese Society of Neuropathology 2015 Aug 35 (4): 324-35. Ogura Ryosuke, Tsukamoto Yoshihiro, Natsumeda Manabu, Isogawa Mizuho, Aoki Hiroshi, Kobayashi Tsutomu, Yoshida Seiichi, Okamoto Kouichiro, Takahashi Hitoshi, Fujii Yukihiko, Kakita Akiyos |
|
Combined ATRX/IDH1 immunohistochemistry predicts genotype of oligoastrocytomas.
Histopathology 2015 May . Hewer Ekkehard, Vajtai Istvan, Dettmer Matthias S, Berezowska Sabina, Vassella Er |
|
ATRX and IDH1-R132H immunohistochemistry with subsequent copy number analysis and IDH sequencing as a basis for an "integrated" diagnostic approach for adult astrocytoma, oligodendroglioma and glioblastoma.
Acta neuropathologica 2015 Jan 129 (1): 133-46. Reuss David E, Sahm Felix, Schrimpf Daniel, Wiestler Benedikt, Capper David, Koelsche Christian, Schweizer Leonille, Korshunov Andrey, Jones David T W, Hovestadt Volker, Mittelbronn Michel, Schittenhelm Jens, Herold-Mende Christel, Unterberg Andreas, Platten Michael, Weller Michael, Wick Wolfgang, Pfister Stefan M, von Deimling Andre |
|
IDH1 and IDH2 mutations in different histologic subtypes and WHO grading gliomas in a sample from Northern Brazil.
Genetics and molecular research : GMR 2015 14 (2): 6533-42. Pessôa I A, Sagica F E S, Anselmo N P, Brito J R N, de Oliveira E H |
|
Targetable signaling pathway mutations are associated with malignant phenotype in IDH-mutant gliomas.
Clinical cancer research : an official journal of the American Association for Cancer Research 2014 Jun 20 (11): 2898-909. Wakimoto Hiroaki, Tanaka Shota, Curry William T, Loebel Franziska, Zhao Dan, Tateishi Kensuke, Chen Juxiang, Klofas Lindsay K, Lelic Nina, Kim James C, Dias-Santagata Dora, Ellisen Leif W, Borger Darrell R, Fendt Sarah-Maria, Vander Heiden Matthew G, Batchelor Tracy T, Iafrate A John, Cahill Daniel P, Chi Andrew |
|
An analysis of the prognostic value of IDH1 (isocitrate dehydrogenase 1) mutation in Polish glioma patients.
Molecular diagnosis & therapy 2014 Feb 18 (1): 45-53. Lewandowska Marzena Anna, Furtak Jacek, Szylberg Tadeusz, Roszkowski Krzysztof, Windorbska Wies?awa, Rytlewska Joanna, Jó?wicki Wojcie |
|
Correlation of IDH1/2 mutation with clinicopathologic factors and prognosis in anaplastic gliomas: a report of 203 patients from China.
Journal of cancer research and clinical oncology 2014 Jan 140 (1): 45-51. Zhang Chuan-Bao, Bao Zhao-Shi, Wang Hong-Jun, Yan Wei, Liu Yan-Wei, Li Ming-Yang, Zhang Wei, Chen Ling, Jiang T |
|
Combining two biomarkers, IDH1/2 mutations and 1p/19q codeletion, to stratify anaplastic oligodendroglioma in three groups: a single-center experience.
Journal of neuro-oncology 2013 Aug 114 (1): 85-91. Frenel J S, Leux C, Loussouarn D, Le Loupp A-G, Leclair F, Aumont M, Mervoyer A, Martin S, Denis M G, Campone |
|
Glioblastoma with oligodendroglial component represents a subgroup of glioblastoma with high prevalence of IDH1 mutation and association with younger age.
Journal of neuro-oncology 2013 May 112 (3): 439-48. Ha Sang Yun, Kang So Young, Do In-Gu, Suh Yeon-L |
|
1p/19q codeletion and IDH1/2 mutation identified a subtype of anaplastic oligoastrocytomas with prognosis as favorable as anaplastic oligodendrogliomas.
Neuro-oncology 2013 Mar . Jiang H, Ren X, Cui X, Wang J, Jia W, Zhou Z, Lin S |
|
[Relationship between IDH1 mutation and clinic pathologic features in human supratentorial WHO grade II gliomas].
Sichuan da xue xue bao. Yi xue ban = Journal of Sichuan University. Medical science edition 2013 Jan 44 (1): 60-3. Tang Jun-Jia, Xie Fei, Wang Xiang, Zhang Dou-Dou, Liu Shuang, Liu Yan-Hui, Mao Qi |
|
Molecular investigation of isocitrate dehydrogenase gene (IDH) mutations in gliomas: first report of IDH2 mutations in Indian patients.
Asian Pacific journal of cancer prevention : APJCP 2013 14 (12): 7261-4. Das Bibhu Ranjan, Tangri Rajiv, Ahmad Firoz, Roy Arnab, Patole Kamlak |
|
Prognostic value of isocitrate dehydrogenase 1, O6-methylguanine-DNA methyltransferase promoter methylation, and 1p19q co-deletion in Japanese malignant glioma patients.
World journal of surgical oncology 2013 11 (1): 284. Takahashi Yoshinobu, Nakamura Hideo, Makino Keishi, Hide Takuichiro, Muta Daisuke, Kamada Hajime, Kuratsu Jun-Ic |
|
IDH1 and IDH2 mutations, immunohistochemistry and associations in a series of brain tumors.
Journal of neuro-oncology 2011 Nov 105 (2): 345-57. Mellai Marta, Piazzi Angela, Caldera Valentina, Monzeglio Oriana, Cassoni Paola, Valente Guido, Schiffer Davi |
|
Molecular markers in low-grade gliomas: predictive or prognostic?
Clinical cancer research : an official journal of the American Association for Cancer Research 2011 Jul 17 (13): 4588-99. Hartmann Christian, Hentschel Bettina, Tatagiba Marcos, Schramm Johannes, Schnell Oliver, Seidel Clemens, Stein Robert, Reifenberger Guido, Pietsch Torsten, von Deimling Andreas, Loeffler Markus, Weller Michael, |
|
Molecular classification of low-grade diffuse gliomas.
The American journal of pathology 2010 Dec 177 (6): 2708-14. Kim Young-Ho, Nobusawa Sumihito, Mittelbronn Michel, Paulus Werner, Brokinkel Benjamin, Keyvani Kathy, Sure Ulrich, Wrede Karsten, Nakazato Yoichi, Tanaka Yuko, Vital Anne, Mariani Luigi, Stawski Robert, Watanabe Takuya, De Girolami Umberto, Kleihues Paul, Ohgaki Hiro |
- Page last reviewed:Oct 1, 2020
- Page last updated:May 05, 2021
- Content source: